Browsing by Author "omur aydin"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group
    (2023) SEÇIL KEPIL ÖZDEMIR; Gülfem Çelik; omur aydin; Ebru Damadoglu; ayse baccioglu; Sevim Bavbek; Dane Ediger; Ferda Oner Erkekol; Bilun Gemicioglu; Rana Işık; AYSE FÜSUN KALPAKLIOGLU; Ali Fuat Kalyoncu; GÜL KARAKAYA; Metin KEREN; Dilşad Mungan; I.Kivilcim Oguzulgen; Fusun Yildiz; Insu Yilmaz; arzu yorgancıoglu
    Introduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be associated with favorable asthma outcomes. However, asthma con- trol is still reported to be below expectations all around the world. Research in the last decades focusing on the use of ICS/formoterol both as maintenance and as needed (maintenance and reliever therapy approach) showed improved asthma outcomes. As a result of recent developments, Turkish Asthma Guidelines group aimed to revise asthma treatment recommendations. In general, we recommend physi- cians to consider the risk factors for poor asthma outcomes, patients’ compliance and expectations and then to determine “a personalized treatment plan.” Importantly, the use of short-acting beta-2 agonists alone as a symptom reliever in asthma patients not using regular ICS is no longer recommended. In stepwise treatment approach, we primarily recommend to use ICS-based controllers and initiate ICS as soon as possible. We define 2 different treatment tracks in stepwise approaches as maintenance and reliever therapy or fixed-dose therapy and equally recommend each track depending on the patient’s risks as well as decision of physicians in a personalized manner. For both tracks, a strong recommendation was made in favor of using add-on treatments before initiating phenotype-specific treatment in step 5. A strong recommendation was also made in favor of using biologic agents and/or aspirin treatment after desensitization in severe asthma when indicated.
  • No Thumbnail Available
    Item
    Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter study
    (2024) SEVGI BEHIYE SARYAL; Fusun Yildiz; arzu yorgancıoglu; Gülfem Çelik; omur aydin; tuncalp demir; Bilun Gemicioglu; Esen Kıyan; Dilşad Mungan; I.Kivilcim Oguzulgen; MEHMET POLATLI; Ozlem GOKSEL; Abdullah Sayiner; ATİLLA HALİL ELHAN; oznur yıldız; Ilknur Basyigit; YAVUZ HAVLUCU; Gulfer Okumus; Murat Türk; ELIF SEN; Sermin Borekci; Nurhayat Yıldırım
    Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter study Introduction: Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) have a greater disease burden than those with COPD or asthma alone. In this study, it was aimed to determine the prevalence, risk factors, and clinical features of ACO because there are limited national data in Türkiye. Materials and Methods: The study was conducted in a cross-sectional design in nine tertiary-care hospitals. The patients followed with a diagnosis of asth- ma or COPD for at least one year were enrolled in the study. The frequency of ACO and the characteristics of the patients were evaluated in the asthma and COPD groups. Results: The study included 408 subjects (F/M= 205/203, mean age= 56.24 ± 11.85 years). The overall prevalence of ACO in both groups was 20.8% (n= 85). The frequency was higher in the COPD group than in the asthma group (n= 55; 33.3% vs. n= 22; 9.8%), respectively (p= 0.001). Patients with ACO had similarities to patients with COPD in terms of advanced age, sex, smoking, exposure to biomass during childhood, being born in rural areas, and radio- logic features. Characteristics such as a history of childhood asthma and allergic rhinitis, presence of chronic sinusitis, NSAID hypersensitivity, atopy, and high eosinophil counts were similar to those of patients with asthma (p< 0.001). The annual decline in FEV 1 was more prominent in the ACO group (mean= -250 mL) than in the asthma (mean change= -60 mL) and COPD (mean change= -230 mL) groups (p= 0.003). Conclusion: This study showed that ACO was common among patients with asthma and COPD in tertiary care clinics in our country. ACO should be considered in patients with asthma and COPD who exhibit the abovemen- tioned symptoms.
  • No Thumbnail Available
    Item
    Elderly and aged asthma have different characteristics: results of a multicenter study
    (2024) Ebru Damadoglu; OZGE OZTURK AKTAS; Bilun Gemicioglu; nafiye yılmaz; fulsen bozkus; VEHBİ AYHAN; AYSE FÜSUN KALPAKLIOGLU; Ferda Oner Erkekol; YAVUZ HAVLUCU; FUAT EREL; omur aydin; Aydanur Ekici; ayse baccioglu; SERAP ARGUN BARIS; Gözde Köycü Buhari; Berrin Ceyhan; Ozlem GOKSEL; mehmet köse; Adile Berna Dursun; Fusun Yildiz; arzu yorgancıoglu; Rana Işık; Dane Ediger; I.Kivilcim Oguzulgen; ahmet demir; GÜL KARAKAYA; Ali Fuat Kalyoncu
    Background/ aim: Characteristics of asthma in the elderly population is not well-known. The aim of the present study was to evaluate asthma in the elderly population, to compare disease characteristics between patients diagnosed <60 (aged asthma) and ≥60 (elderly asthma) years of age. Materials and methods: The study was a prospective, multicenter, cross-sectional type. A questionnaire was filled out to patients 60 years of age and over, that have been followed for asthma for at least 3 months. Asthma Control Test (ACT), eight-item Morisky Medication Adherence Scale (MMAS-8) was filled out, inhaler device technique was assessed. Results: A total of 399 patients were included from 17 tertiary care centers across the country. Mean age was 67.11 years and 331 (83%) were female. The age at asthma diagnosis was ≥60 in 146 (36.6%) patients. Patients diagnosed ≥60 years were older (p < 0.001), had higher education level (p < 0.001), more commonly had first-degree relative with asthma (p = 0.038), asthma related comorbidities (p = 0.009) and accompanying rhinitis/rhinosinusitis (p = 0.005), had better asthma control (p = 0.001), were using less controller medications (p = 0.014). Inhaler technique was correct in 37% of the patients with no difference in between the groups. Treatment compliance was better in elderly asthma patients (p < 0.001). In the multivariate logistic regression analysis, having well-controlled asthma (odds ratio = 1.61, CI = 1.04–2.51), and high medication adherence rate (odds ratio = 2.43, CI = 1.48–4.0) were associated with being in the elderly asthma group. Conclusion: The characteristics of asthma are different among patients aged 60 years and over which seems to be related to onset age of asthma. In our cohort, the elderly asthma patients had higher education level, and treatment adherence and asthma control was better. Patients diagnosed ≥60 years of age did not have more severe disease.